CDMO’s Milan site now has clearances from both U.S. and European regulators to supply patients with HSC-based gene therapy using approved commercial processes “We congratulate Orchard for reaching ...

HEIDELBERG, Germany--(BUSINESS WIRE)-- AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality.

SEATTLE, June 3, 2020 /PRNewswire/ -- AGC Biologic s, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that it will partner with Novavax, Inc.

SEATTLE--(BUSINESS WIRE)--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a Lentiviral vector (LVV) expansion to its ...

Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites Novelty Nobility develops innovative antibody drugs, including bispecific antibodies and ...

SEATTLE--(BUSINESS WIRE)--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a capacity update with the addition of three new ...

Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of Excellence Asimov, the synthetic biology ...

The Global CDMO’s Seattle site continues work on this new T1D treatment, the first and only treatment approved to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged ...

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional de Vigilância Sanitária (Anvisa), Brazil’s health ...

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approved With the decision by the U.S. Food and Drug ...

AGC Biologics, a CDMO, and BioConnection, a CMO, agreed to partner to provide end-to-end biopharmaceutical development and manufacturing capabilities for drug substance and drug product using the ...

Japan’s AGC Biologics and contract manufacturing specialist BioConnection are teaming up to offer drug development and production services to the biopharma industry and to provide an alternative to ...